HyperQ Stress

Non-invasive diagnosis of ischaemic heart disease

Revolutionising the detection of coronary artery disease


Coronary Artery Disease (CAD) screening is largely based on exercise ECG testing that has a limited diagnostic accuracy, especially in women. Additionally, there are growing concerns over exposure to radiation and cutbacks on payment for costly cardiac imaging.


HyperQ Stress ECG testing provides a low-cost, non-invasive, radiation-free and highly reliable first line CAD diagnostic solution for private cardiology practices as well as cardiology departments in hospitals. HyperQ is based on solid scientific and clinical research.



  • Higher sensitivity in diagnosing ischaemia
  • Fewer false alarms in non-ischaemic patients
  • Ima podjednako dobar učinak i kod žena i kod muškaraca
  • Pruža jasne rezultate kod pacijenata sa dvosmislenim rezultatima standardnog EKG testa opterećenja

Availability in your market is subject to regulatory approval.